Secondly, calcineurin is implicated in the regulation of tau phosphorylation, hyperphosphorylation of which is one of the pathological signatures of AD (Poppek et al., 2006; Lloret et al., 2011). This evidence concerns the gene MAPT and Alzheimer disease.